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Abstract
Leptin is a key regulator of energy intake and expenditure. This peptide hormone is
expressed in mouse white adipose tissue, but hardly expressed in 3T3-L1 adipocytes.
Using bisulfite sequencing, we found that CpG islands in the leptin promoter are highly
methylated in 3T3-L1cells. 5-azacytidine, an inhibitor of DNA methyltransferase, markedly
increased leptin expression as pre-adipocytes matured into adipocytes. Remarkably, leptin
expression was stimulated by insulin in adipocytes derived from precursor cells exposed to
5-azacytidine, but suppressed by thiazolidinedione and dexamethasone. In contrast, adipo-
cytes derived from untreated precursor cells were unresponsive to both 5-azacytidine and
hormonal stimuli, although lipid accumulation was sufficient to boost leptin expression in the
absence of demethylation. Taken together, the results suggest that leptin expression in
3T3-L1 cells requires DNA demethylation prior to adipogenesis, transcriptional activation
during adipogenesis, and lipid accumulation after adipogenesis.
Introduction
Obesity is now considered a global epidemic [1], with over 60% of adults in the United States
being obese or overweight [2]. Obesity is due to an imbalance between energy intake and
expenditure, and is associated with type 2 diabetes, hypertension, and other cardiovascular dis-
eases [3]. Excess energy is stored as triacylglycerides in white adipose tissue (WAT), which fur-
ther regulates energy homeostasis by secreting adipocytokines like adiponectin and leptin.
Leptin is a 16-kDa peptide hormone expressed from the Ob gene [4]. It suppresses food
intake [4], and stimulates energy expenditure [5, 6]. Because circulating levels of leptin posi-
tively correlate with body mass index and fat mass [7], it is believed to be a signaling molecule
that transmits signals from the peripheral to the central nervous system. In addition, leptin-
deficient mice are obese, and have severe type 2 diabetes [4]. These observations highlight the
need to elucidate the mechanisms that drive leptin expression in adipocytes.
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Adipocyte cell lines such as 3T3-L1 or 3T3-F442A are widely used as models of adipocyte
biology. These cells have fibroblast-like morphology, but they may be induced to accumulate
triacylglycerides and become adipocyte-like. Nevertheless, differentiated 3T3-L1 or 3T3-F442A
adipocytes express leptin at significantly lower levels than adipose tissue [8], and are insensitive
to hormones like insulin [8, 9]. These properties preclude characterization of leptin expression.
On the other hand, isolated primary adipocytes are challenging to manipulate genetically, or to
maintain in the adipocyte state for a sufficiently long time.
Methylation, specifically of cytosines in CpG sites, is one of the several epigenetic mecha-
nisms that suppress gene expression. Methylation generally prevents transcriptional factors
from binding to promoters [10], and recruits transcriptional repressors such as MeCP2 [11].
Consequently, the expression of genes with CpG-rich promoters tends to depend on the meth-
ylation status. Indeed, the leptin promoter is CpG-rich, and methylation downregulates its
activity [12]. Nevertheless, it is unclear whether methylation suppresses leptin expression in
3T3-L1 adipocytes. The aim of this study was to define the role of DNAmethylation in leptin
expression in cultured 3T3-L1 cells, and in obesity-induced hyperleptinemia. In addition, we
wanted to establish an adipocyte cell line that expresses leptin at in vivo levels.
Materials and Methods
Cell culture and 5-azacytidine treatment
3T3-L1 pre-adipocytes, kindly provided by Dr. Hosaka at Kyorin University, Tokyo, Japan,
were grown to confluence at 37°C and 7.5% CO2/air in high-glucose Dulbecco’s Modified
Eagle’s Medium (DMEM, Sigma, MO, USA) supplemented with 10% calf serum (Thermo
Fisher Scientific, MA, USA). Cells were differentiated two days after reaching confluence by
replacing the media with DMEM containing 10% fetal bovine serum (GE Healthcare, Little
Chalfont, UK), 10 μg/mL insulin (Wako, Tokyo, Japan), 500 μM isobutylmethylxanthine
(Sigma, MO, USA), 1 μM dexamethasone (Wako, Tokyo, Japan), and 1μM troglitazone (Cay-
man Chemical, MI, USA). After another two days, media were replaced with 10% fetal bovine
serum in DMEM, and refreshed daily thereafter. To inhibit methylation, 3T3-L1 pre-adipo-
cytes were cultured for seven days in DMEM supplemented with 10% calf serum and 0.5–5 μM
5-azacytidine (Sigma, MO, USA). Media were replaced every other day and cells were subse-
quently differentiated and maintained as described. Cells were harvested at day 0 and day 6–8.
Construction of reporter plasmids
A fragment of the mouse leptin promoter between -154 and +60 bp was amplified by PCR
using mouse genomic DNA and primer pairs with sequence 50-cagctagccgcctagaatggagcactagg-
30 and 50-ttagatctaagactggtggaggagaaagtagg-30 containing NheI and BglII restriction sites
(underlined). The PCR product was inserted into pGL 4.19 (Promega, WI, USA) using a liga-
tion kit (TaKaRa, Tokyo, Japan), andconfirmed by DNA sequencing.
In vitromethylation of leptin promoter
The mouse leptin promoter was excised from pGL4.19 using NheI and BglII, and purified by
gel electrophoresis. The insert (100 ng) was methylated with 4 U SssI methyltranseferase (NEB,
MA, USA). Methylated and mock-methylated DNA fragments were then re-ligated into pGL
4.19, and purified by phenol chloroform extraction. Methylation was confirmed by digestion
with SmaI, which recognizes CCCGGG, and is sensitive to methylation.
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Transfection
3T3-L1 pre-adipocytes were transfected with plasmids or siRNA using Lipofectamine 2000
(Invitrogen, CA, USA), following the manufacturer’s protocol. Briefly, 3T3-L1 pre-adipocytes
were seeded one day prior to transfection in antibiotic-free DMEM supplemented with 10%
calf serum. siRNA and Lipofectamine 2000 were separately diluted at the appropriate ratio in
OptiMEM Reduced SerumMedium (Invitrogen, CA, USA), pooled, mixed gently, incubated
for 20 min at room temperature, and added to cells. DNMT1 was silenced using siRNAs [13]
with sense sequence gcugggagauggcgucaua[dT][dT], and antisense sequence uaugacgccaucucc-
cagc[dT][dT]. Non-Targeting siRNA (GE Healthcare, Little Chalfont, UK, #D001206-14-05)
was used as control. Cells were transfected with siRNA three times [13]
For reporter gene analysis, differentiated 3T3-L1 adipocytes were electroporated using
NEPA 21 system (NEPA GENE, Chiba, Japan) according to the manufacturer’s protocol.
Briefly, cells were trypsinized, washed in OptiMEM Reduced SerumMedium, suspended in
OptiMEM Reduced SerumMedium at 50 × 104 /100 μL, and transferred to a 0.2 mm gap
cuvette. Cells were then mixed with 250 ng promoter plasmid, 250 ng β-galactosidase internal
control, and 30 μg sonicated salmon sperm DNA (BioDynamics, Tokyo, Japan). After electro-
poration, 3T3-L1 adipocytes were plated in 24 well plates and cultured in 10% fetal bovine
serum in DMEM for 24 h before use.
Luciferase assay
Transfected 3T3-L1 adipocytes were harvested in lysis buffer supplied with Luciferase Assay
Kit (Promega, WI, USA). The lysate was analyzed for luciferase activity according to the manu-
facturer’s protocol, and results were normalized to β-galactosidase activity.
RNA isolation and reverse transcription PCR
mRNA was isolated from cultured cells or animal tissues using Trizol Reagent (Invitrogen, CA,
USA), reverse-transcribed using TaKaRa PrimeScript RT reagent kits (TaKaRa, Tokyo, Japan),
and analyzed by quantitative real-time PCR on a LightCycler System (Roche Diagnostics,
Tokyo, Japan). Gene expression was normalized to 18S ribosomal RNA. The following primers
were used: 50-gactcccacagatggtccctac-30 and 50-ctgcctaaaacccctgatgagt-30 for DNMT1; 50-gagg
actccatcacggtggg-30 and 50-aagaagaggcggccagtacc-30 for DNMT3a; 50-agccacccaagttgtaccca-30
and 50-acagttcccacagcgatgga-30 for DNMT3b; 50-agggaggaaaatgtgctgga-30 and 50-ggtgaagcccag
gaatgaag-30 for leptin; 50-ggtgaagcccaggaatgaag-30 and 50-gaaagccagtaaatgtagag-30 for adiponec-
tin; 50-ccagagcatggtgccttcgct-30 and 50-cagcaaccattgggtcagctc-30 for PPARγ; 50-ccgcagacgacag
ga-30 and 50-ctcatgccctttcataaact-30 for 442/aP2; 50-acggtcttcacgttggtctc-30 and 50-ctcaaagaaggc
cacaaagc-30 for GLUT4; and 50-agcaacgagtaccgggtacg-30 and 50-tgtttggctttatctcggctc-30 for
C/EBPα.
Animal studies and adipose tissue collection
Male C57BL/6 mice were obtained from Charles River Laboratory Japan, Inc. (Yokohama,
Japan). From the age of four weeks, mice were fed control diet (Oriental Yeast, Tokyo, Japan)
or D12492 high-fat diet (Research Diets, NJ, USA) containing 60% fat. Animal studies were
performed according to guidelines of the Animal Research Committee of Tokushima Univer-
sity, and were approved by the Animal Research Committee of Tokushima University. Mice
were humanely sacrificed by cervical dislocation.
White adipose tissues were collected from epididymal fat pads, minced, and digested for 45
min at 37°C in PBS(-) supplemented with 2% bovine serum albumin (Sigma, MO, USA) and
DNAMethylation Suppresses Leptin Expression in Adipocytes
PLOS ONE | DOI:10.1371/journal.pone.0160532 August 5, 2016 3 / 13
2500 units/mL type II collagenase (Worthington, OH, USA). Digests were then incubated for
15 min in 10 mM EDTA, and passed through 250-μm nylon mesh. The filtrate was centrifuged
at 1,200 rpm for 5 min at 4°C. Adipocytes and stromal vascular fractions were recovered from
the supernatant and pellet, respectively.
Isolation of genomic DNA and pyrosequencing
Genomic DNA was extracted frommouse tissues and 3T3-L1 cells using GenElute Mammalian
Genomic DNAMini-Prep Kit (Sigma, MO, USA), processedwith Epitect Plus Bisulfite Conver-
sion Kit (Qiagen, CA, USA), and amplified with Pyromark Q24 PCR Kit (Qiagen, CA, USA).
PCR products were used directly for analysis of DNA methylation by PyroMark Q24 (Qiagen,
CA, USA), following the manufacturer’s instructions. The primers 50-gtttagaatggagtattaggttg-30
and biotin-50-cctccttcttcttacctcaattt-30 were used to amplify the leptin promoter, while 50-
attaggttgttgttgtta-30 and 50-taggtaggtatggag-30 were used as sequencing primers.
Immunoblotting
Cells were lysed in lysis buffer (20 mM Tris-HCl pH 7.4, 150 mMNaCl, 1% sodium deoxycho-
late, 0.1% SDS, 1% NP-40, and 2 mM EDTA). The resulting lysates were resolved by electro-
phoresis and transferred to polyvinylidene difluoride membranes (Millipore, MA, USA). Blots
were probed overnight (14–16 h) at 4°C with primary antibodies diluted 1/500-1/1000, labeled
for 1 h with secondary antibody conjugated to horseradish peroxidase, and developed with
Clarity Western ECL Substrate (BioRad, CA, USA). Blots were probed with antibodies against
mouse ERK (Cell Signaling, MA, USA #9101), DNMT1 (Cell Signaling, MA, USA #5119), and
leptin (Santa Cruz, TX, USA #sc-842).
ELISA
Cells were starved without serum for 4 h, and then incubated in antibiotic- and serum-free
DMEM for another 24 h. The concentration of leptin in the culture media was determined by
Mouse Leptin ELISA KIT (Shibayagi, Gunnma, Japan AKRLP-011).
Statistical analysis
Data were analyzed by unpaired Student’s t test, and p values< 0.05 were considered
significant.
Results and Discussion
Leptin promoter is highly methylated in 3T3-L1 adipocytes
Leptin mRNA was expressed less abundantly in 3T3-L1 adipocytes than in white adipose tis-
sue, while mRNA levels of adiponectin were comparable (Fig 1A and 1B). We then investigated
sequences -119 to +47 bp of the leptin transcription start site (S1 Fig), as this region was
reported to be functionally significant [14]. We found that CpG sites in this fragment were
highly methylated in cultured adipocytes than in mouse tissues (Fig 1D), implying that hyper-
methylation of the promoter suppresses leptin expression.
5-azacytidine induces leptin expression through DNA demethylation
The difference in expression between 3T3-L1 adipocytes and white adipose tissue is believed to
be due to methylation, which modulates the accessibility of regulatory cis-elements [10–12].
Therefore, we hypothesized that demethylation of the leptin promoter may induce expression
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in 3T3-L1 cells. Treatment of mature adipocytes with 5-azacytidine, an inhibitor of DNA
methyltransferase [15], did not affect the methylation status and activity of the leptin promoter
(data not shown). Similarly, the inhibitor did not induce expression in pre-adipocytes,
although DNA methylation was reduced to levels comparable to that in white adipose tissue
(Fig 2A and 2B). However, leptin expression increased 5.2- and 37.5-fold when pre-adipocytes
were differentiated after treatment with 0.5 and 5.0 μM 5-azacytidine, respectively (Fig 2C and
2D). Accordingly, the amount of protein increased in cell lysates and culture media, as mea-
sured by western blot and ELISA (Fig 2E and 2F). We also directly tested whether DNA meth-
ylation affects promoter activity, and found that DNA methylation suppressed gene reporter
expression by about 80% (Fig 2G).
Notably, in the present study, leptin synthesis is hormonally regulated in adipocytes differ-
entiated from precursor cells exposed to 5-azacytidine. leptin expression in these adipocytes
was stimulated 2-fold by insulin, but was significantly suppressed by dexamethasone and thia-
zolidinedione (Fig 2H). In contrast, adipocytes derived from untreated pre-adipocytes did not
respond to these hormones (Fig 2H). Early studies suggested that leptin responds to nutritional
stimuli and hormones like insulin. However, the effects of hormones on leptin transcription
remain controversial. For instance, insulin was observed to stimulate leptin expression in some
in vitro studies [16, 17], but not in others [8, 9] as we observed in adipocytes derived from
untreated precursors.
We believe that variability in leptin sensitivity to insulin may be due to differences in
DNA methylation. Methylation is considered to be a mechanism of adaptation to environ-
mental conditions, and methylation marks are known to change dramatically in response to
environmental changes, including cell culture conditions. Indeed, some in vitro studies dem-
onstrated that DNA methylation patterns change depending on passage and other culture
conditions [18, 19]. Thus, it is possible that 3T3-L1 cells insensitive to insulin, including
ours, may have undergone hypermethylation, while cells responsive to insulin may have
undergone demethylation.
Fig 1. Methylation status and leptin expression. A, B: Leptin (A) and adiponectin (B) mRNA expression in epididymal (eWAT) and subcutaneous
white adipose tissue (sWAT) frommice at age 12 weeks, and in 3T3-L1 adipocytes. C: Percentage of CpGs methylated in the leptin promoter in eWAT,
sWAT, and 3T3-L1 cells. In A, B, C, data are mean ± SEM and *; p < 0.05, **; p < 0.01 versus eWAT.
doi:10.1371/journal.pone.0160532.g001
DNAMethylation Suppresses Leptin Expression in Adipocytes
PLOS ONE | DOI:10.1371/journal.pone.0160532 August 5, 2016 5 / 13
Fig 2. Effects of demethylation on leptin expression in 3T3-L1 cells. A, B: Promoter methylation (A) and leptin expression (B) in 3T3-L1 pre-
adipocytes treated with 0.5 or 5 μM 5-azacytidine for 7 days. C, D: Promoter methylation (C) and leptin expression (D) in adipocytes derived from
3T3-L1 precursors treated with or without 5-azacytidine, measured 6 days after differentiation. Products from real-time qPCRwere also separated
on agarose. E, F: Expression (E) and secretion (F) of leptin in adipocytes derived from precursors treated with 5-azacytidine, as measured by
western blotting and ELISA, respectively. Data were normalized to total protein concentration. G: Activity of methylated and unmethylated leptin
promoter in adipocytes differentiated from 3T3-L1 cells. H: Leptin expression in serum-starved cells treated with 100 nM insulin (Ins), 1 μM
troglitazone (Tro), or 1 μM dexamethasone (Dex). Cells are adipocytes derived from 3T3-L1 precursors treated with 5-azacytidine. Results are
mean ± SEM. *, p < 0.05; **, p < 0.01 versus untreated cells in A-F, versus methylated promoter in G, and versus vehicle in H.
doi:10.1371/journal.pone.0160532.g002
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Methylation and other epigenetic marks were previously reported to regulate adipogenic
differentiation[20]. Thus, we investigated the effects of demethylation on lipid accumulation,
adipogenic gene expression, and mitotic clonal expansion, which are key early steps in adipo-
genesis[21]. 5-Azacytidine did not affect lipid accumulation and mitotic clonal expansion (Fig
3A and 3B), and the effects on adipocyte gene expression were small but measurable (Fig 3C
and 3G). These results indicate that leptin expression due to prior exposure to 5-azacytidine is
not exclusively due to enhanced adipogenesis.
DNMT1 silencing induces DNA demethylation and leptin expression
DNAmethylation patterns are established and maintained by DNA methyltransferases
(DNMTs), of which three types, namely DNMT1, DNMT3a, and DNMT3b, have been identi-
fied in mammals [22]. DNMT3a and DNMT3b create new methylation marks [23, 24], while
DNMT1 preserves marks established during DNA replication [25, 26]. DNA methylation was
Fig 3. Effects of 5-azacytidine on adipogenesis in 3T3-L1 precursors treated with or without 5-azacytidine. A: Lipid accumulation,
as visualized with Oil Red O in cells fixed in 3.7% formaldehyde. B: Cell proliferation. C-G: Expression of the adipocyte-specific genes
PPARγ (C), C/ EBPα (D), aP2 (E), GLUT4 (F), and adiponectin (G). Results are mean ± SEM. *, p < 0.05; **, p < 0.01.
doi:10.1371/journal.pone.0160532.g003
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reduced in cells exposed to 5-azacytidine before differentiation. However, 5-azacytidine did
not affect methylation patterns in differentiated adipocytes, strongly indicating that the inhibi-
tor decreases methylation by inhibiting DNMT1.Therefore, we investigated the effects of sup-
pressing DNMT1 expression by siRNA. Silencing reduced DNMT1 expression in 3T3-L1 pre-
adipocytes by 80%, as confirmed by quantitative real-time PCR and western blotting (Fig 4A
and 4B). Consequently, DNAmethylation diminished (Fig 4C), and cells abundantly expressed
leptin upon differentiation (Fig 4D), even though mitotic clonal expansion and expression of
other adipocyte genes were not dramatically affected (Fig 4E and 4F). These data strongly sug-
gest that the effects of 5-azacytidine on DNA methylation and leptin expression are due to loss
of DNMT1 activity.
Leptin expression during adipocyte hypertrophy is not due to
demethylation
In rodents [4] and humans [27], leptin is primarily expressed in adipose tissues, and DNA
modifications such as methylation may facilitate such tissue specificity. For instance, insulin
promoters in mice and humans are uniquely demethylated in pancreatic beta cells [28, 29].
Similarly, we found the leptin promoter to be highly methylated in tissues other than white adi-
pose (Fig 5A).
Obesity-induced hyperinsulinemia boosts leptin expression in white adipose tissues [30–
32], although adipocyte hypertrophy also upregulates leptin expression on its own [33, 34].
Hence, we hypothesized that demethylation drives leptin expression during hypertrophy and
we tested this hypothesis in vitro and in vivo.
Considering that whole adipose tissue consists of adipocytes and other cells with highly
methylated DNA (Fig 5B), we measured methylation status only in adipocytes from mice on
high-fat or normal chow diets. We found high-fat diet to slightly increase methylation of the
leptin promoter (Fig 5C).
On the other hand, we induced adipocyte hypertrophy in 3T3-L1 cells by long-term culture.
Leptin mRNA dramatically increased at day 6 in adipocytes derived from precursor cells
treated with 5-azacytidine, and continued to rise gradually thereafter. In contrast, leptin
expression became detectable beginning at day 8 in cells derived from untreated pre-adipo-
cytes, and increased thereafter (Fig 5D). Notably, the methylation status of the leptin promoter
did not change between day 6 and day 20 in both untreated (Fig 5E) and 5-azacytidine-treated
3T3-L1 adipocytes (Fig 5F). Taken together, these observations imply that methylation marks
in mature adipocytes are persistent, even though precursor cells may undergo changes in meth-
ylation patterns in response to stimuli. This conclusion is inconsistent with the notion that obe-
sity-induced leptin expression is due to demethylation. Indeed, relatively high levels persist in
long-term cultures without changes in methylation, suggesting that alternative mechanisms are
involved.
We did not examine variables other than adipocyte hypertrophy and obesity. For instance,
dietary factors are likely to impact DNA methylation, as has been demonstrated in cases of
intrauterine growth retardation due to severe nutritional deficiency. In animals, deficiency in
methyl nutrients such as choline, methionine, and vitamin B12 was reported to reduce methyl-
ated cytosines in the liver [35]. Remarkably, changes in methylation were reversed upon return
to a standard diet, indicating that methylation marks are dynamic, even in adult organisms.
Nevertheless, we found demethylation to be important, but not sufficient, to induce leptin
release in 3T3-L1 cells. In particular, the data indicate that 5-azacytidine does not induce leptin
transcription in pre-adipocytes, even though it blocks promoter methylation (Fig 2B and 2D).
Indeed, leptin dramatically increases in abundance only after 6 days of differentiation in vitro
DNAMethylation Suppresses Leptin Expression in Adipocytes
PLOS ONE | DOI:10.1371/journal.pone.0160532 August 5, 2016 8 / 13
Fig 4. Effects of DNMT1 knockdown in 3T3-L1 pre-adipocytes. A, B: DNMT1mRNA (A) and protein (B). C, D: Promoter
methylation (C) and leptin expression (D). E: Expression of the adipogenic genes, PPARγ, C/EBPα, aP2, GLUT4,
adiponectin, and leptin. F: Cell proliferation. Results are mean ± SEM. *, p < 0.05; **, p < 0.01 versus non-targeting siRNA in
A-D, and versus 0 h in F.
doi:10.1371/journal.pone.0160532.g004
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Fig 5. Effects of adipocyte enlargement. A: CpGmethylation in eWAT, liver, skeletal muscle, and brain tissue frommice 12 weeks of age. B: CpG
methylation in adipocytes and stromal vascular fraction of whole adipose tissue. C: Methylation in adipocytes isolated from eWAT of mice on normal chow
(NC) or high-fat (HF) diet. D: Time course of leptin expression in adipocytes differentiated from untreated or 5-azacytidine-treated 3T3-L1 precursors. E, F:
Leptin promoter methylation at day 6 and 20 in adipocytes derived from untreated (E) and 5-azacytidine-treated (F) 3T3- L1 pre-adipocytes. Data are
mean ± SEM. *, p < 0.05; **, p < 0.01 versus eWAT (A), adipocytes (B), normal chow (C), untreated cells (D), and day 6 (E-F).
doi:10.1371/journal.pone.0160532.g005
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(Fig 5D). This result suggests that the required transcription factors appear during late adipo-
genesis. C/EBPα is potentially one such factor, as it was reported to bind sequences -55 to -47
bp from the transcription start site [14, 36]. In mice, CpG islands in this putative C/EBPα-
binding site are hypermethylated in tissues other than white adipose (Fig 5A), implying that
this element is physiologically significant. However, transient overexpression of C/EBPα in
3T3-L1 adipocytes treated with 5-azacytidine did not activate leptin transcription (data not
shown), indicating that it is not involved. Hence, further studies are required to identify the
transcription factors that regulate leptin expression.
In summary, we found that DNA demethylation via 5-azacytidine induces leptin expression
in 3T3-L1 cells that are differentiated after exposure to the inhibitor. Based on experiments
with these cells, we discovered that DNAmethylation before adipogenesis, transcriptional acti-
vation during adipogenesis, and adipocyte hypertrophy after adipogenesis are key events that
regulate leptin expression. We anticipate that these cells will become a useful resource in inves-
tigating leptin expression.
Supporting Information
S1 Fig. Leptin promoter. Sequences -119 to +47 bp of the transcription start site in leptin are
underlined. This region contains 10 CpG sites, which are highlighted in gray.
(PDF)
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